Sign in
  Edit search
Intrathecal rituximab treatment for pediatric post-transplan…
Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
Article, Chapter
Authors: G van de Glind
Publication: Pediatric Blood and Cancer, Volume:50, Issue:4
Published: Wiley, 2008
ISSN: 1545-5009
  Full text availability for this item
View Full Text Source:Pediatric Blood and Cancer,Pediatric Blood and Cancer,Wiley Online Library Database Model 2021 Opens in new Window
Journal:  Pediatric Blood and Cancer Source:Wiley Online Library Database Model 2021 Opens in new Window
Collection:  Wiley Online Library Database Model 2021 Opens in new Window
Coverage:
  • 2004~present; volume:42~present;issue:1~present
View Full Text Source:Pediatric Blood and Cancer,Pediatric Blood and Cancer,Wiley Online Library: Complete Journals Opens in new Window
Journal:  Pediatric Blood and Cancer Source:Wiley Online Library: Complete Journals Opens in new Window
Collection:  Wiley Online Library: Complete Journals Opens in new Window
Coverage:
  • 2004-01-01~present; volume:42~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item